Health
Three common medications lower risk and mortality for lung cancer – Medical Xpress
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).
All three medications are commonapproximately 35 million people take a statin to control cholesterol; more than 120 million people take metformin to control diabetes; and between 6 and 10 million people take aspirin daily.
The aim of this study was to investigate the associations of aspirin, metformin, and st…
-
Noosa News23 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General22 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General19 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General13 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore